• Home
  • Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.

Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.

Author List
Prasad G, Sottero T, Yang X, Mueller S, James CD, Weiss WA, Polley MY, Ozawa T, Berger MS, Aftab DT, Prados MD, Haas-Kogan DA
Publication
Neuro-oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1481370
Publication Year
2011
PubMed ID
21317208
Publication Title
Prasad G, Sottero T, Yang X, Mueller S, James CD, Weiss WA, Polley MY, Ozawa T, Berger MS, Aftab DT, Prados MD, Haas-Kogan DA. Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide. Neuro Oncol. 2011 Apr; 13(4):384-92.